Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 06, 2013 08:30 ET | Source: BG Medicine, Inc.

BG Medicine to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday, March 13, 2013

WALTHAM, Mass., March 6, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Wednesday, March 13 at 8:30 a.m. Eastern...
February 27, 2013 08:30 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. to Present at Cowen and Company 33rd Annual Health Care Conference

WALTHAM, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) ), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today...
February 27, 2013 08:30 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Announces Publication of Two Studies Supporting Repeat Galectin-3 Testing in Heart Failure Patients

WALTHAM, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, announced today...
January 30, 2013 16:09 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Announces Closing of Public Offering and Exercise of Over-Allotment Option

WALTHAM, Mass., Jan. 30, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, today announced...
January 25, 2013 09:17 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Prices $12.0 Million Public Offering of Common Stock

WALTHAM, Mass., Jan. 25, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, today announced...
January 24, 2013 16:34 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Enters Into $12 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC

WALTHAM, Mass., Jan. 24, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today announced that...
January 24, 2013 16:34 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. Announces Proposed Public Offering of Common Stock

WALTHAM, Mass., Jan. 24, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today announced that...
January 02, 2013 16:05 ET | Source: BG Medicine, Inc.

BG Medicine Announces Obtaining CE Mark and Launching of Automated BGM Galectin-3 Test

WALTHAM, Mass., Jan. 2, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
December 11, 2012 08:30 ET | Source: BG Medicine, Inc.

BG Medicine Obtains CE Mark for CardioSCORE(TM) Test in Europe

WALTHAM, Mass., Dec. 11, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, today announced...
November 20, 2012 16:58 ET | Source: BG Medicine, Inc.

BG Medicine, Inc. to Present at 24th Annual Piper Jaffray Healthcare Conference

WALTHAM, Mass., Nov. 20, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...